Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study
胆囊收缩素 2 受体激动剂 177Lu-PP-F11N 用于甲状腺髓样癌的放射性核素治疗：Lumed 0a 期研究结果
期刊:Journal of Nuclear Medicine
影响因子:9.1
doi:10.2967/jnumed.119.233031
Christof Rottenburger, Guillaume P Nicolas, Lisa McDougall, Felix Kaul, Michal Cachovan, A Hans Vija, Roger Schibli, Susanne Geistlich, Anne Schumann, Tilman Rau, Katharina Glatz, Martin Behe, Emanuel R Christ, Damian Wild
